FDA Provides New Guidance on U.S. Prescription Drugs Supply Chain
WASHINGTON, D.C. — The following quote is attributed to Donald D. Ashley, J.D., Director of the Office of Compliance for FDA’s Center for Drug Evaluation and Research:
Read MoreSupply chain security